143
Participants
Start Date
May 8, 2020
Primary Completion Date
January 31, 2021
Study Completion Date
February 2, 2021
NORS (Nitric Oxide Releasing Solution)
NORS treatment will consist of daily self-administration of three routes; Nitric Oxide Gargle (NOG) every morning, Nitric Oxide Nasophyaryngeal Irrigation (NONI) every evening, and Nitric Oxide Nasal Spray (NONS) up to 5 times per day.
NORS (Nitric Oxide Releasing Solution)
"Up to ten volunteers who are found to be COVID-19 positive during screening will be eligible to enroll in the 21-day Treatment sub-study and receive daily NORS treatment for 14 days. NORS treatment will consist of daily self-administration of three routes; Nitric Oxide Gargle (NOG) every morning, Nitric Oxide Nasophyaryngeal Irrigation (NONI) every evening, and Nitric Oxide Nasal Spray (NONS) up to 5 times per day.~Any participants enrolled in the Prevention study who meet the criteria for the sub study will roll over into the Treatment Sub-Study but must remain in their randomly assigned group."
BC Diabetes, Vancouver
LMC Manna, Pointe-Claire
Diex Recherche Québec, Québec
Diex Recherche Joliette, Saint-Charles-Borromée
Diex Recherche Sherbrooke, Sherbrooke
Collaborators (1)
The Emmes Company, LLC
INDUSTRY
Keyrus Life Science
NETWORK
Sanotize Research and Development corp.
INDUSTRY